NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 40 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,726,999 | +0.2% | 45,000,000 | 0.0% | 1.68% | +10.3% |
| Q2 2023 | $38,654,893 | +11.8% | 45,000,000 | +12.5% | 1.53% | +13.4% |
| Q1 2023 | $34,578,496 | +0.6% | 40,000,000 | +4.2% | 1.35% | +0.9% |
| Q4 2022 | $34,368,176 | +1.0% | 38,391,000 | 0.0% | 1.34% | +2.2% |
| Q3 2022 | $34,038,000 | +1.2% | 38,391,000 | 0.0% | 1.31% | -2.7% |
| Q2 2022 | $33,633,000 | -36.7% | 38,391,000 | -34.3% | 1.34% | -18.9% |
| Q1 2022 | $53,156,000 | +24.8% | 58,391,000 | +25.9% | 1.66% | +25.0% |
| Q4 2021 | $42,604,000 | – | 46,391,000 | – | 1.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 46,391,000 | $42,604,000 | 1.32% |
| Lombard Odier Asset Management (Europe) Ltd | 171,980 | $15,871,000 | 0.70% |
| WOLVERINE ASSET MANAGEMENT LLC | 80,367,000 | $73,232,000 | 0.68% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,419,000 | $5,736,000 | 0.39% |
| LINDEN ADVISORS LP | 63,485,000 | $58,560,000 | 0.36% |
| Ionic Capital Management LLC | 3,000,000 | $2,771,000 | 0.35% |
| SSI INVESTMENT MANAGEMENT LLC | 5,859,000 | $5,354,000 | 0.31% |
| Verition Fund Management LLC | 33,485,000 | $30,766,000 | 0.22% |
| Nicholas Investment Partners, LP | 3,550,000 | $3,244,000 | 0.20% |
| TFG Asset Management GP Ltd | 3,000,000 | $2,769,000 | 0.17% |